Transcription Factor Screening for Homogeneous hiPSC Differentiation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current stem cell differentiation protocols are multifaceted, yield heterogeneous populations, and lack robust, efficient methods for converting human induced pluripotent stem cells (hiPSCs) to specific cell types, with high failure rates due to experimental and technical variability.
Innovation Solution
A systematic, unbiased open reading frame (ORF) screen using a comprehensive library of transcription factors (TFs) is employed to induce differentiation and maintain pluripotency in hiPSCs, utilizing nucleic acids encoding TFs or their activators to increase TF expression, achieving rapid and efficient conversion to desired cell types.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If multifaceted differentiation protocols are used, then stem cells can be converted to various cell types, but the resulting populations are highly heterogeneous and mask the cell type of interest
Solution Approach 1:
The patent applies local quality by using cell type-specific transcription factors that act locally on particular gene regulatory networks. Each TF targets specific lineage-determining genes, creating localized transcriptional changes that drive uniform differentiation into a specific cell type rather than heterogeneous populations.
Solution Approach 2:
The patent changes the parameter of transcriptional control by introducing exogenous transcription factors that directly bind to DNA and alter gene expression patterns. This shifts the differentiation process from being driven by multiple signaling cascades to being controlled by specific transcriptional parameters, resulting in more homogeneous cell populations.
2Reliability
If biologically-inspired transcription factors are selected, then some cell types can be generated successfully, but the failure rate is relatively high with unexpected cell fates
Solution Approach 1:
The patent applies universality by using a standardized set of transcription factor delivery vectors and expression systems that can be applied across different cell type conversions. The same basic approach (viral or non-viral delivery of TFs) works for generating multiple different cell types, reducing the complexity of troubleshooting while maintaining high success rates.
Solution Approach 2:
The patent incorporates feedback mechanisms through the use of inducible expression systems and screening assays that allow researchers to monitor differentiation progress and adjust TF expression levels accordingly. This feedback control helps prevent unexpected cell fates and improves the reliability of cell type conversion.
3Productivity
If forced transcription factor induction is used, then cell identity conversion can be achieved efficiently, but experimental and technical variability makes troubleshooting difficult
Solution Approach 1:
The patent applies segmentation by dividing the differentiation process into distinct modular steps: (1) delivery of transcription factors using standardized vectors, (2) controlled expression through inducible promoters, and (3) monitoring through specific assays. This segmentation allows each step to be optimized and troubleshooted independently, reducing overall protocol complexity while maintaining high efficiency.
4Reliability
If labor-intensive culturing techniques are used, then pluripotency can be maintained, but the process is delicate and not robust for downstream applications
Solution Approach 1:
The patent applies self-service by using defined culture media formulations that contain all necessary components for maintaining pluripotency without requiring feeder cells or complex supplement additions. The media itself provides the necessary growth factors and signaling molecules, making the system self-sufficient and easier to operate while maintaining reliable pluripotency.
Data Source
Figure 1
Figure 2
Figure 3
AI summary
Forced expression of a handful of transcription factors (TFs) can induce conversions between cell identities; however, the extent to which TFs can alter cell identity has not been systematically assessed. Here, we assembled a human TFome, a comprehensive expression library of 1,578 human TF clones with full coverage of the major TF families. By systematically screening the human TFome, we identified 77 individual TFs that induce loss of human-induced-pluripotent- stem-cell (hiPSC) identity, suggesting a pervasive ability for TFs to alter cell identity. Using large-scale computational cell type classification trained on thousands of tissue expression profiles, we identified cell types generated by these TFs with high efficiency and speed, without additional selections or mechanical perturbations. TF expression in adult human tissues only correlated with some of the cell lineage generated, suggesting more complexity than observation studies can explain.